Andrey Dvorkin

Andrey Dvorkin has a strong background in investment banking and M&A within the healthcare and life sciences sector. Andrey currently holds the position of Director in Healthcare and Life Sciences M&A at Harris Williams, starting in November 2022. Prior to that, they worked as a Director in Healthcare Investment Banking at Piper Sandler from June 2021 to November 2022.

Andrey also has extensive experience at Rothschild & Co, where they held multiple roles. Andrey served as an Assistant Director in Healthcare M&A from March 2019 to June 2021. Before that, they worked as an Associate in Healthcare M&A from June 2016 to March 2019 and as an Analyst in M&A from June 2012 to June 2016.

Before joining Rothschild & Co, Andrey gained early experience as an Intern in Investment Banking at Merrill Lynch from November 2011 to June 2012 and as an Intern in Investment Banking at Credit Suisse from June 2011 to August 2011.

Andrey Dvorkin attended Lomonosov Moscow State University (MSU) from 2007 to 2013, where they studied nanotechnologies. Additionally, in 2010, they briefly attended Stanford University, focusing on investment science and international investments. In 2009, they also had a short stint at The London School of Economics and Political Science (LSE), focusing on international relations. No specific degree names were provided for these educational experiences.